tiprankstipranks
Prime Medicine, Inc. (PRME)
NASDAQ:PRME
US Market

Compare Prime Medicine, Inc. (PRME) vs. Competitors

866 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Prime Medicine, Inc.
$3.54
$633.74M
-2.57
180.80%
4 Buy
1 Hold
0 Sell
Strong Buy
Immatics
$10.53
$1.43B
-5.79
163.86%
6 Buy
0 Hold
0 Sell
Strong Buy
Relay Therapeutics
$14.51
$2.68B
-5.25
552.17%
8 Buy
0 Hold
0 Sell
Strong Buy
Taysha Gene Therapies
$4.55
$1.33B
-16.13
285.83%
9 Buy
0 Hold
0 Sell
Strong Buy
Sana Biotechnology
$3.21
$832.62M
-4.22
101.29%
5 Buy
0 Hold
0 Sell
Strong Buy
Upstream Bio, Inc.
$30.30
$567.06M
-10.19
59.57%
6 Buy
1 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
PRME
Prime Medicine, Inc.
3.51
2.34
200.00%
IMTX
Immatics
10.66
6.69
168.51%
RLAY
Relay Therapeutics
15.00
12.78
575.68%
TSHA
Taysha Gene Therapies
4.63
3.46
295.73%
SANA
Sana Biotechnology
3.12
1.59
103.92%
UPB
Upstream Bio, Inc.
10.42
4.02
62.81%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts